Show simple item record

FieldValueLanguage
dc.contributor.authorReyes, Leila
dc.date.accessioned2018-12-17
dc.date.available2018-12-17
dc.date.issued2018-08-06
dc.identifier.urihttp://hdl.handle.net/2123/19667
dc.description.abstractOxidative stress is a major feature of cardiac ischaemia/reperfusion (I/R) injury, with strong evidence implicating infiltrating leukocytes, in particular neutrophils, as a major source of oxidants in the infarcted myocardium. Activated leukocytes release the peroxidase enzyme, myeloperoxidase (MPO), which can produce the oxidants hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN). Chapter 3 examines the differential cellular effect of (patho)-physiological levels of HOCl and HOCN in cardiomyocytes. Both HOCl and HOSCN induced cellular damage characteristic of cardiac I/R injury and highlighted two very different cellular responses in cardiomyocytes. Chapter 4 explored the therapeutic effect of selenium supplements, specifically, the dietary supplement selenomethionine (SeMet) as a form of antioxidant therapy in the in vitro cardiomyocyte model exposed to HOCl and HOSCN or hypoxia/re-oxygenation (H/R). SeMet prevented a range of cellular damage mediated by HOCl, with the protection mainly attributed to the direct scavenging ability of SeMet. In contrast, SeMet was not able to protect against the HOSCN or H/R injury induced damage. Studies were extended in Chapter 5 to examine SeMet’s ability to modulate the cellular damage observed in an experimental in vivo model of cardiac I/R injury. SeMet (2 mg kg-1) for 8 weeks resulted in the elevation of tissue selenium levels and reduced apoptosis mediated by acute I/R injury, but not the accompanying cardiac dysfunction, adverse remodelling or impaired cardiac function during late stage I/R injury. Overall, this Thesis contributed to knowledge regarding the role of HOCl and HOSCN in cardiac I/R injury, with the results suggesting that both oxidants may contribute to oxidative stress and the associated downstream cellular damage. Furthermore, this work shows that SeMet could be beneficial as secondary treatment for cardiac I/R injury and be used in conjunction with current treatment methods.en
dc.rightsThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en
dc.subjecthypochlorous aciden
dc.subjecthypothiocyanous aciden
dc.subjectmyeloperoxidaseen
dc.subjectseleniumen
dc.subjectselenomethionineen
dc.subjectischaemia/reperfusionen
dc.titleInvolvement of inflammatory oxidants in cardiac ischaemia/reperfusion injuryen
dc.typeThesisen
dc.type.thesisDoctor of Philosophyen
usyd.facultyFaculty of Medicine and Healthen
usyd.departmentHeart Research Instituteen
usyd.degreeDoctor of Philosophy Ph.D.en
usyd.awardinginstThe University of Sydneyen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.